Camrelizumab Plus Chemotherapy: clinical trials recruiting now
Fewer than 3 recruiting trials found.
2
Recruiting trials
7
Conditions studied
0
US states with sites
1
Countries
Phase breakdown
Phase 2 1
Phase 3 1
Conditions being studied
| Condition | Trials |
|---|---|
| Biomarkers / Blood | 1 |
| Breast cancer | 1 |
| IMMUNOTHERAPY | 1 |
| Lung cancer | 1 |
| Neoadjuvant Therapy | 1 |
| Resectable Lung Non-Small Cell Carcinoma | 1 |
| TNBC - Triple-Negative Breast Cancer | 1 |
Recruiting trials involving Camrelizumab Plus Chemotherapy
- A Study of Camrelizumab Plus Chemotherapy in Combination With or Without Famitinib as Neoadjuvant Therapy in Participants With Triple Negative Breast Cancer (BCTOP-T-N01)
- Neoadjuvant Camrelizumab Combined With Chemotherapy for Resectable Stage IIIA-IIIB NSCLC
Common questions
How many recruiting trials involve Camrelizumab Plus Chemotherapy?
2 recruiting trials across 7 conditions.
Is this list of trials complete?
No. For the full record, search ClinicalTrials.gov.